Utilizza questo identificativo per citare o creare un link a questo documento:
http://elea.unisa.it/xmlui/handle/10556/6221
Record completo di tutti i metadati
Campo DC | Valore | Lingua |
---|---|---|
dc.contributor.author | Rosato, Valerio | - |
dc.date.accessioned | 2022-10-28T10:37:26Z | - |
dc.date.available | 2022-10-28T10:37:26Z | - |
dc.date.issued | 2021-05-07 | - |
dc.identifier.uri | http://elea.unisa.it:8080/xmlui/handle/10556/6221 | - |
dc.identifier.uri | http://dx.doi.org/10.14273/unisa-4309 | - |
dc.description | 2019 - 2020 | it_IT |
dc.description.abstract | Introduction: Non-Alcoholic Fatty Liver Disease encompasses a spectrum of diseases ranging from simple steatosis to steatohepatitis (or NASH), up to cirrhosis and hepatocellular carcinoma(HCC). The challenge is to recognize the more severe and/or progressive pathology. A reliable non-invasive method does not exist. Untargeted metabolomics is a novel method to discover biomarkers and give insights on diseases pathophysiology. Objectives: we applied metabolomics to understand if simple steatosis, steatohepatitis and cirrhosis in NAFLD patients have peculiar metabolites profiles that can differentiate them among each-others and from controls. Methods: Metabolomics signatures were obtained from 307 subjects from two separated enrollments. The first collected samples from 69 controls and 144 patients (78 steatosis, 23 NASH, 15 NASH-cirrhosis, 8 HCV-cirrhosis, 20 cryptogenic cirrhosis). The second, used as validation-set, enrolled 44 controls and 50 patients (34 steatosis, 10 NASH and 6 NASH-cirrhosis). The “Partial-Least-Square Discriminant-Analysis” (PLS-DA) was used to reveal class separation in metabolomics profiles between patients and controls and among each class of patients, and to reveal the metabolites contributing to class differentiation. Results: Several metabolites were selected as relevant, in particular: Glycocholic acid, Taurocholic acid, Phenylalanine, branched-chain amino acids increased at the increase of the severity of the disease from steatosis to NASH, NASH-cirrhosis, while glutathione decreased (p<0.001 for each). Moreover, an ensemble machine learning (EML) model was built using 10 different classification models. EML showed accuracy>80% in NAFLD evolution steps prediction. Conclusions: Metabolomics profiles of NAFLD patients could be a useful tool to non-invasively diagnose NAFLD and discriminate among the various stages of the disease, giving insights into its pathophysiology. [edited by Author] | it_IT |
dc.language.iso | en | it_IT |
dc.publisher | Universita degli studi di Salerno | it_IT |
dc.subject | Cirrhosis | it_IT |
dc.subject | NAFLD | it_IT |
dc.subject | Untargeted metabolomics | it_IT |
dc.title | Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis | it_IT |
dc.type | Doctoral Thesis | it_IT |
dc.subject.miur | MED/09 MEDICINA INTERNA | it_IT |
dc.contributor.coordinatore | Monteleone, Palmiero | it_IT |
dc.description.ciclo | XXXIII ciclo | it_IT |
dc.contributor.tutor | Persico, Marcello | it_IT |
dc.identifier.Dipartimento | Medicina, Chirurgia ed Odontoiatria "Scuola medica salernitana" | it_IT |
È visualizzato nelle collezioni: | Medicina traslazionale dello sviluppo e dell’invecchiamento attivo |
File in questo documento:
File | Descrizione | Dimensioni | Formato | |
---|---|---|---|---|
tesi di dottorato V. Rosato.pdf | tesi di dottorato | 1,05 MB | Adobe PDF | Visualizza/apri |
tesi di dottorato - presentazione V. Rosato.pptx | tesi di dottorato - presentazione | 22,51 MB | Microsoft Powerpoint XML | Visualizza/apri |
Tutti i documenti archiviati in DSpace sono protetti da copyright. Tutti i diritti riservati.